News

AA Thornton welcomes Formalities Officer from the EPOs placement programme ‘Praktika Extern’

AA Thornton welcomes Formalities Officer from the EPOs placement programme ‘Praktika Extern’ We were delighted to welcome Kamila Miklos, a Formalities Officer from the European Patent Office (EPO) Hague office to our office this week as part of our ongoing support of the EPOs placement programme ‘Praktika Extern’. In previous years we have hosted EPO… Read more »

Partner Ian Gill celebrates 25 years at AA Thornton

Partner Ian Gill reflects on spending 25 years at AA Thornton and his career in Intellectual Property.    If you can’t view the embedded article above, we have provided an accessible version below: A quick search on Google reveals that Gary Larson announced he was no longer doing the “Far Side” cartoons on 3 October… Read more »

AA Thornton are ranked in the Legal 500 2020

AA Thornton is ranked as a top tier firm The Legal 500 2020 edition has now been published and we are absolutely delighted to be recommended as a top-tier firm for our trade marks practice, which was described as “strong”, “dedicated” and an “excellent team of knowledgeable and genuinely good people”. We also remain highly recommended for our patents… Read more »

AA Thornton welcome two new Partners

AA Thornton appoint two new Partners in their Litigation Department The Partners of AA Thornton are delighted to announce the appointment of Simon Spink and Dan Byrne, who recently joined the firm as Partners in the Litigation department. Commenting on the appointment, Geoff Hussey, Partner said: “I am absolutely delighted that such highly skilled and experienced… Read more »

Promoting a career in ideas

AA Thornton team welcomes year 12 students into the world of IP This week we were delighted to welcome a group of year 12 students from St Marylebone School into our London office as part of our IP Inclusive initiative to raise the profile of the various careers in the Intellectual Property industry.  We spent… Read more »

The New SPC Manufacturing Waiver Regulation

The New SPC Manufacturing Waiver Regulation Today, 1 July 2019,  a new EU Regulation No 2019/933 (the ‘Regulation’) amending the current SPC Regulation 469/2009 comes into force. This introduces limitations to the extent of SPC protection in respect of certain acts carried out in relation to the export of a medicinal product to a non-EU… Read more »

Biosimilars and patents

The majority of the world’s biggest selling medicines can be classified as “biologics” or “biopharmaceuticals”. Such medicines contain one or more biologically active product produced from (or containing components of) living organisms as the active ingredients.   Biosimilars are biological products which are highly similar in structure, biological activity, efficacy, safety and immunogenicity profile to… Read more »

Categories

Archives